These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 26616366)

  • 1. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker Identification through Proteomics in Colorectal Cancer.
    Martín-García D; García-Aranda M; Redondo M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
    Reumer A; Maes E; Mertens I; Cho WC; Landuyt B; Valkenborg D; Schoofs L; Baggerman G
    Expert Rev Proteomics; 2014 Aug; 11(4):449-63. PubMed ID: 24702250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
    Ang CS; Baker MS; Nice EC
    Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics for early detection of colorectal cancer: recent updates.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
    You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
    J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
    Tomonaga T; Kume H
    Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative mass spectrometry for colorectal cancer proteomics.
    Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
    Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Profiling for Colorectal Cancer Biomarker Discovery.
    Álvarez-Chaver P; De Chiara L; Martínez-Zorzano VS
    Methods Mol Biol; 2018; 1765():241-269. PubMed ID: 29589313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
    Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.